 |
|
Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
Patrick Biggar, Gheun-Ho Kim
Kidney Res Clin Pract. 2017;36(3):209-223. Published online 2017 Sep 30 DOI: https://doi.org/10.23876/j.krcp.2017.36.3.209
|
|
Citations to this article as recorded by
 Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
Bashaer M Muhammad-Baqir, Evan Noori Hameed, Rawaa Hadi Shareef, Mustafa H Ahmed
Medical Journal of Babylon.2023; 20(3): 558. CrossRef Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
Juan Antonio Requena-Ibáñez, Carlos G. Santos-Gallego, Anderly Rodriguez-Cordero, M. Urooj Zafar, Juan José Badimon
Cardiovascular Drugs and Therapy.2022; 36(6): 1187. CrossRef Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner
Ole Heinisch, Thomas Zeyen, Tobias Goldmann, Marco Prinz, Michael Huber, Jennifer Jung, Eren Arik, Shahin Habib, Alexander Slowik, Arno Reich, Jörg B. Schulz, Pardes Habib
Translational Stroke Research.2022; 13(3): 462. CrossRef Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients
Masaomi Nangaku, Youssef M K Farag, Emil deGoma, Wenli Luo, Dennis Vargo, Zeeshan Khawaja
Nephrology Dialysis Transplantation.2021; 36(7): 1244. CrossRef Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients
Ahmet Tufekci, Ekrem Kara
Sleep and Breathing.2021; 25(2): 897. CrossRef The impact of arteriovenous fistulas and tunneled cuffed venous catheters on morbidity and mortality in hemodialysis patients: A single center experience
Serhat Celik, Ebru Gok Oguz, Gulay Ulusal Okyay, Tamer Selen, Mehmet Deniz Ayli
The International Journal of Artificial Organs.2021; 44(4): 229. CrossRef Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Bartłomiej Borawski, Jacek Stanislaw Malyszko, Marlena Kwiatkowska, Jolanta Malyszko
Journal of Clinical Medicine.2021; 10(18): 4149. CrossRef Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis
Matthew A. Held, Emily Greenfest-Allen, Edward Jachimowicz, Christian J. Stoeckert, Matthew P. Stokes, Antony W. Wood, Don M. Wojchowski
Experimental Hematology.2020; 84: 29. CrossRef Microparticles derived from human erythropoietin mRNA-transfected mesenchymal stem cells inhibit epithelial-to-mesenchymal transition and ameliorate renal interstitial fibrosis
Mirae Lee, Seok-hyung Kim, Jong Hyun Jhee, Tae Yeon Kim, Hoon Young Choi, Hyung Jong Kim, Hyeong Cheon Park
Stem Cell Research & Therapy.2020;[Epub] CrossRef Hepcidin as a Biomarker of Cardiorenal Syndrome
Gheun-Ho Kim
Journal of Korean Medical Science.2020;[Epub] CrossRef Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease
Ughetta del Balzo, Pierre E. Signore, Gail Walkinshaw, Todd W. Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael P. Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David
The Journal of Pharmacology and Experimental Therapeutics.2020; 374(2): 342. CrossRef Relationship between Cardiac Geometry and Serum Hepcidin in Chronic Kidney Disease: Analysis from the KNOW-CKD Study
Hyang Ki Min, Yun Kyu Oh, Kyu Hun Choi, Kyu Beck Lee, Sue K. Park, Curie Ahn, Sung Woo Lee
Journal of Korean Medical Science.2020;[Epub] CrossRef Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?
Muhammad Hasan Shahab, Shahzeen Saifullah Khan
Cureus.2020;[Epub] CrossRef DIBc nano metal-organic framework improves biochemical and pathological parameters of experimental chronic kidney disease
Saideh Fakharzadeh, Hassan Argani, Peyman Mohammadi Torbati, Simin Dadashzadeh, Somayeh Kalanaky, Mohammad Hassan Nazaran, Abbas Basiri
Journal of Trace Elements in Medicine and Biology.2020; 61: 126547. CrossRef The Influence of Inflammation on Anemia in CKD Patients
Anna Gluba-Brzózka, Beata Franczyk, Robert Olszewski, Jacek Rysz
International Journal of Molecular Sciences.2020; 21(3): 725. CrossRef Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling
Matthew A. Held, Emily Greenfest-Allen, Su Su, Christian J. Stoeckert, Matthew P. Stokes, Don M. Wojchowski
Cellular Signalling.2020; 69: 109554. CrossRef Erythropoietin protects neurons from apoptosis via activating PI3K/AKT and inhibiting Erk1/2 signaling pathway
Wei Si, Jianyi Wang, Mei Li, Hao Qu, Ran Gu, Rui Liu, Lu Wang, Shirong Li, Xiao Hu
3 Biotech.2019;[Epub] CrossRef Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients
Luciano A. Pedrini, Adam M. Zawada, Anke C. Winter, Jenny Pham, Gudrun Klein, Melanie Wolf, Astrid Feuersenger, Pio Ruggiero, Annalisa Feliciani, Carlo Barbieri, Adelheid Gauly, Bernard Canaud, Stefano Stuard, Wisit Cheungpasitporn
PLOS ONE.2019; 14(2): e0212795. CrossRef Definition and Validation of a Novel Metric of Erythropoiesis‐Stimulating Agent Response in Hemodialysis Patients
Calvin J. Meaney, Spinel Karas, Ben Robinson, Jamie Gaesser, Alan Forrest, Wojciech Krzyzanski, Mandip Panesar, Gauri G. Rao
The Journal of Clinical Pharmacology.2019; 59(3): 418. CrossRef Clinical effectiveness and safety of erythropoietin‐stimulating agents for the treatment of low‐ and intermediate‐1−risk myelodysplastic syndrome: a systematic literature review
Sophie Park, Peter Greenberg, Aylin Yucel, Caroline Farmer, Frank O'Neill, Cisio De Oliveira Brandao, Pierre Fenaux
British Journal of Haematology.2019; 184(2): 134. CrossRef Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
Maciej Drozdz, André Weigert, Fatima Silva, João Frazão, Abdulkareem Alsuwaida, Mahesh Krishnan, Werner Kleophas, Szymon Brzosko, Fredrik K. Johansson, Stefan H. Jacobson
BMC Nephrology.2019;[Epub] CrossRef Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats
Sua Kim, Chor Ho Jo, Gheun-Ho Kim
Hypertension Research.2019; 42(12): 1905. CrossRef Hepcidin Therapeutics
Angeliki Katsarou, Kostas Pantopoulos
Pharmaceuticals.2018; 11(4): 127. CrossRef
|